secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2025-10-29T23:59:59+00:00
Accession:  0001493152-25-020058
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PURE Bioscience FY2025 net product sales $2.2M, net loss narrows to $2.4M from $3.4M
--------------------------------------------------------------------------------

- Net product sales $2,198K for FY2025, up 12.4% from $1,955K in FY2024.
- Net loss improved to ($2.4M) from ($3.4M); loss per share ($0.02) vs ($0.03).
- Net cash used in operations ($2.0M) vs ($2.5M) in prior year.
- Expanded distribution with Hydrite Chemical; launched membrane treatment for dairy/beverage.
- Excluding share-based compensation, net loss was ($2.3M) vs ($3.1M).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315225020058/0001493152-25-020058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315225020058/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-020058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer